← Eichor
Condition: Oropharynx Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Oropharynx

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Personalized Elective Neck Irradiation Guided by Sentinel Lymph Node Biopsy in Larynx and Pharynx Cancer. The PRIMO Stud
Phase 3 · 9 location(s) · Radboud University Medical Center · NCT05333523Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patient
Phase 2 · 153 location(s) · NRG Oncology · NCT06532279Lymphocyte-Sparing And Radio-Immunotherapy in Head and Neck Carcinoma
Phase 3 · 8 location(s) · Centre Leon Berard · NCT06706401COMBO Endoscopy Oropharyngeal Airway in Sedated Endoscopic Retrograde Cholangiopancreatography for Patients
Phase 2 · 2 location(s) · Zhejiang University · NCT07012772A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Ca
Phase 3 · 205 location(s) · Merus B.V. · NCT06525220Evaluation of the Benefit of a New Surgical Procedure According to IDEAL Recommendations for ORL Cancer Patients: the Ex
NA · 4 location(s) · Institut Claudius Regaud · NCT05757817Prospective Observational Study to Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in HPV-associated OPSCC
Phase N/A · 3 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT04564989The Sinai Robotic Surgery Trial in HPV-related Oropharyngeal Squamous Cell Carcinoma (SIRS 2.0 Trial)
Phase 2 · 2 location(s) · Icahn School of Medicine at Mount Sinai · NCT05419089De-escalation of Adjuvant Radiation for Low-Risk HPV Oropharyngeal Cancers
NA · 1 location(s) · Georgetown University · NCT06554158De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA
Phase 2 · 3 location(s) · Mayo Clinic · NCT05541016Identification of Individual Histological and Blood Markers in Patients With Recurrent or Metastatic Upper Aerodigestive
NA · 3 location(s) · Fondation Hôpital Saint-Joseph · NCT06061705Detection of Oral and Throat Cancers Using OralViome Cancer Testing System
Phase N/A · 1 location(s) · Viome · NCT05451303Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION)
Phase 2 · 1 location(s) · Medical University of South Carolina · NCT07513389Strengthening Inspiratory and Oropharyngeal Muscles in Moderate Obstructive Sleep Apnea Hypopnea Syndrome
NA · 2 location(s) · Centre Hospitalier Universitaire de Saint Etienne · NCT06471751BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or S
Phase 2 · 225 location(s) · National Cancer Institute (NCI) · NCT05136196Intranasal WSK-IM05 Vaccine Plus Tislelizumab as Neoadjuvant Therapy for HPV+ OPSCC
Phase 1 · 1 location(s) · West China Hospital · NCT07565740Oropharyngeal Candidiasis (OPC) and S-ECC
Phase N/A · 1 location(s) · Temple University · NCT05761197Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-esca
Phase 2 · 1 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT07209189Cemiplimab and Cetuximab Prior Salvage Surgery in Patients With Recurrent Oral Cavity and HPV-negative Oropharyngeal Squ
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT06448026Immune Biomarker Study for Cisplatin-ineligible Patients Receiving Chemoradiotherapy With Docetaxel
Phase N/A · 1 location(s) · University of Erlangen-Nürnberg Medical School · NCT06947668Adaptive De-intensified Radiotherapy Using Circulating Tumor DNA in HPV- Associated Oropharyngeal Cancer
Phase 2 · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT06323460Treatment De-Escalation for Favorable Prognosis Human Papilloma Virus (HPV) or p16-Positive Oropharyngeal Cancer Receivi
NA · 2 location(s) · Georgetown University · NCT06902623Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
Phase 1 · 18 location(s) · National Cancer Institute (NCI) · NCT05172245A Proof of Concept Trial Investigating Safety and Efficacy of APG-157 in Oral Dysplasia
Phase 2 · 1 location(s) · Elizabeth J Franzmann · NCT05865028Intratumoral Lidocaine Injection Before Oropharyngeal Cancer Surgery
Phase 1 · 1 location(s) · Ryan Carey · NCT06747390A Study of Reduced Radiation Therapy With Chemotherapy in People With HPV-Positive Throat Cancer
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06984861Study of the Link Between Freezing of Gait and Oropharyngeal Freezing in Parkinson's Patients
Phase N/A · 1 location(s) · Hopital La Musse · NCT06713265Compartmentalized Postoperative Radiotherapy in Head and Neck Cancer
Phase 2 · 3 location(s) · Olgun Elicin · NCT07058805A Mucosal Contouring Method Based on Swallowing-induced Breakthrough Pain for Radiation-induced Oropharyngeal Mucositis
Phase N/A · 1 location(s) · Nanfang Hospital, Southern Medical University · NCT06287788Photon Therapy Versus Proton Therapy in Early Tonsil Cancer.
NA · 12 location(s) · Lund University Hospital · NCT03829033
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.